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The distribution and persistence of cyclobutane pyri-
midine dimers were investigated in mouse skin after
chronic and acute exposures to ultraviolet-B radi-
ation. We found that DNA damage accumulated in
response to chronic irradiation and persisted in a
unique set of epidermal cells located at the basal
layer. Treatment with a tumor promoter caused
the heavily damaged epidermal cells to divide and
p53-immunopositive clusters to form within 24 h
suggesting that these cells may be progenitors of the
mutant p53 clusters associated with actinic keratoses
and squamous cell carcinomas. In contrast to low
¯uence chronic irradiation, daily treatment with a
higher ¯uence of ultraviolet-B produced extensive
hyperplasia and considerably reduced penetration of
photodamage. Exposure of chronically irradiated
skin to an acute ``sunburn dose'' of ultraviolet-B also
produced signi®cant epidermal hyperplasia and
resulted in complete loss of heavily damaged basal
cells within 4 d postirradiation. The occurrence and
distribution of cyclobutane dimers in human skin
correlated well with putative sunlight exposure and
resembled that observed in ultraviolet-B-irradiated
mice. Heavily damaged basal cells were observed at
various sites, including those receiving sporadic sun-
light exposure, suggesting that these cells may play
an important role in carcinoma formation in
humans. Key words: carcinogen-retaining cell/chronic UV
exposure/cyclobutane dimer/hairless mouse/photocarcino-
genesis/promotion/stem cell. J Invest Dermatol 117:590±
595, 2001
S
unlight is a potent and ubiquitous carcinogen responsible
for much of the skin cancer in the human population
today with skin tumors in man accounting for about 30%
of all new cancers reported annually (Cleaver and
Mitchell, 1996). More than 1,000,000 cutaneous malig-
nancies are diagnosed each year in the U.S.A. alone (Miller and
Weinstock, 1994) of which »30,000 are malignant melanomas
(Skolnick et al, 1994). Of the remaining malignancies basal cell
carcinomas occur at about 4-fold greater frequency than squamous
cell carcinomas. Much of the human population is routinely
exposed to low levels of solar ultraviolet-B radiation (UVB), the
dose depending on geographic location, custom, occupation, and
recreational behavior. Indeed, casual exposure to direct sunlight in
the mid-U.S. latitudes is not trivial and may result in the
accumulation of a mean lethal dose to unprotected human cells
within approximately 30 min (Scotto et al, 1983). Recent increases
in melanoma and carcinoma correlate with ozone depletion (de
Gruijl and van der Leun, 1993) and calculations suggest that a 1%
depletion in stratospheric ozone will increase nonmelanoma skin
cancer by about 2.0% (Urbach, 1997). Hence, chronic low level
UV exposure is an important consideration in studies directed
toward determining the etiology and epidemiology of sunlight-
induced skin cancer and in targeting high-risk populations.
Evidence strongly suggests that dimerizations between adjacent
pyrimidine bases by the direct absorption of UVB radiation (290±
320 nm) are the predominant premutagenic events responsible for
the initiation of human basal and squamous cell carcinomas (Brash
et al, 1991). Transition mutations arising chie¯y at the 3¢ base of a
cytosine±thymine dipyrimidine have been found in the p53 tumor
suppressor gene of 50% of human basal cell carcinomas (Ziegler et
al, 1993) and in the ras proto-oncogene in murine tumors at a
much lower rate (Ananthaswamy and Pierceall, 1990). The C mT
and CC mTT tandem double transition mutations are considered
the ``signature mutations'' of solar UVB radiation. The predom-
inant photoproducts occurring at these sites are the cyclobutane
pyrimidine dimer (CPD), pyrimidine(6±4)pyrimidone dimer, and
the Dewar photoisomer of the (6±4) photoproduct. The relative
contribution of these lesions to mutation induction, tumor
initiation, and tumor promotion is the subject of ongoing
investigations.
An important consideration of photocarcinogenesis is the effect
that chronic sunlight exposure may have on the formation and
accumulation of DNA photodamage in the skin. Vink and
coworkers (Vink et al, 1991; 1993) analyzed the induction, repair,
and accumulation of CPD in the skin of UVB-irradiated hairless
mice using immunohistochemistry and found that the accumula-
tion in epidermal cells reached a maximum level after three
exposures (total dose of 4.5 kJ per m2) with the photoproduct
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content in suprabasal cells exceeding that in basal cells. After the
third exposure, CPD levels decreased and the level of damage in
basal cells prior to exposure (i.e., 24 h after the previous exposure)
was at background. More recently, de Gruijl and Berg (1998)
showed that the CPD frequency in the epidermis of chronically
irradiated mice decreased with increasing hyperplasia and became
stationary with time, and that the level of persistent damage
correlated with the daily UVB ¯uence and was inversely related to
tumor latency.
In a recent report (Mitchell et al, 1999), we treated Skh-1 hairless
mice with daily doses of suberythemal UVB for 40 d and analyzed
the amount and distribution of DNA photodamage and DNA
repair using radioimmunoassays and immunohistochemistry. We
found that DNA damage accumulated in mouse skin as a result of
chronic UVB irradiation and that this damage persisted in the
dermis and epidermis for several weeks after the chronic treatment
was terminated. Although the persistent damage was evenly
distributed throughout the dermis, it remained in the epidermis
as a small number of heavily damaged basal cells. In this study, we
investigated the fate of the heavily damaged basal cells in mouse
skin and determined whether similar cells could occur in sun-
exposed human skin.
MATERIALS AND METHODS
Animals and UV irradiations Female hairless mice (Skh:Hr1)
(Charles River), 5±6 wk old at the start of the experiment, were housed
under yellow lights and periodically irradiated under a bank of eight
100 W TL01 ¯uorescent lamps (Philips) emitting predominantly UVB
light [88% UVB (290±320); 6% UVAII (315±340); 6% UVAI (340±400)]
with a peak wavelength at »313 nm. The lights were ®ltered through
UVT cast acrylic (Polycast Technology, Stamford, CT), which excludes
stray light below 280 nm. Under these conditions the minimal erythemal
dose (MED) was estimated to be »3.5 kJ per m2. The ¯uence rate was
measured with an IL1400A radiometer/photometer coupled to an
SEL240/UVB-1/TD detector (International Light, Newburyport, MA).
Animals were exposed to UVR in an irradiation chamber of our design
and manufacture to maximize incident ¯uence uniformity (StarchArt,
Smithville, TX) (for details see Mitchell et al, 1999). The average ¯uence
rate at the level of the dorsum (»20 cm) was 3.8 J per m2 per s and the
total incident dose for each treatment was determined by integrating the
¯uence over the time of exposure. Animals were irradiated at
approximately 24 h intervals (daily) with either 0.5 kJ per m2 (0.1±
0.2 3 MED) or 2 kJ per m2 (0.5±0.75 3 MED) UVB radiation. For
tumor promotion experiments, dorsa were coated with 100 mg per ml
12-O-tetradecanoylphorbol-13-acetate (TPA) diluted in acetone using a
cotton-tipped applicator. Control mice received acetone alone.
Skin biopsies and immunohistochemistry After CO2 asphyxiation
two 1.5 3 2 cm2 sections of skin were excised from the dorsa of four
mice, one from the anterior and one from the posterior. Three to six
5 mm 3 1.5 cm strips were cut from each section, ®xed in 70% ethanol,
and paraf®n-embedded, and 4 mm sections were cut from each. Sections
were extracted from paraf®n blocks by incubation at 60°C for 1 h
followed by four immersions in xylol for 5 min each, rehydrated by
2 min incubations in 100%, 96%, and 70% EtOH, washed in phosphate-
buffered saline (PBS) for 5 min, denatured in 0.1 N NaOH/70% EtOH
for 3 min, dehydrated for 1 min each in 70%, 90%, and 100% EtOH, air
dried, and incubated with proteinase K (10 mg per ml) at 37°C for
10 min. After ®ve washes for 5 min each in PBS sections were incubated
with 5% goat serum for 30 min at 23°C, rewashed ®ve times for 5 min
in PBS, and incubated overnight at 4°C with monoclonal antibody
speci®c for CPD (Kamiya Biomedical) diluted 1:1000 in PBS. Sections
were then washed ®ve times for 5 min each in PBS and incubated with
goat antimouse IgG conjugated with ¯uorescein isothiocyanate (FITC)
(Dianova) diluted 1:100 in PBS. After ®ve additional 5 min washes in
PBS slides were mounted with ``antifade'' [2.3% DABCO (Sigma) in
90% glycerol in 20 mM Tris, pH 8.0] and covered. Sections were
visualized using a CCD camera (Fa. Kappa) coupled to a Leica DM
¯uorescence microscope.
Human skin biopsies were routinely performed on dermatologic
patients at Dermatologisches Zentrum, Buxtehude, Germany, and imme-
diately frozen in liquid nitrogen at ±196°C. Sections (4 mm) were cut
from frozen tissue using a cryostat and after slide preparation were
sequentially ®xed for 5 min in methanol and acetone at ±20°C. After
®xation the slides were stored at ±20°C. The CPD staining protocol was
essentially as described above for mouse skin sections.
For apoptosis sections were ®xed for 10 min in acetone/3% H2O2,
rinsed three times for 2 min each with PBS/0.05% Tween 20,
preincubated for 20 min at 23°C with PBS/Tween containing 10% goat
serum, and incubated for 60 min at 23°C with a 1:100 dilution of a
polyclonal rabbit antih/m caspase 3 (active) (R&D Systems, Cat. #
AF835) in a humidi®ed chamber. Subsequent to primary antibody
treatment a biotin±streptavidin kit (LAB-SA from Zymed) was used for
diaminobenzamide (DAB) visualization of caspase-3-positive cells. For
p53 analysis, sections were deparaf®nized and placed immediately into
0.3% H2O2 in methanol for 20 min, washed three times in PBS/albumin
for 5 min each, and incubated with a rabbit polyclonal antiserum against
mouse p53 protein (CM-5 from Novacastra Laboratories) diluted 1:35 in
PBS/albumin. All incubations were carried out at 23°C. CM-5 antiserum
recognizes both mutant and wild-type p53 protein. The CM-5-positive
cells were visualized using a biotin±strepatavidin±DAB system as
described above.
Quanti®cation and analysis of immunopositive cells For each set
of experimental conditions (i.e., acetone control, 24 and 72 h post-TPA)
four adjacent 4 mm sections were prepared separated from an additional
group of four sections by 20 mm; 10 such areas were prepared from
duplicate mice and each section was examined by three individuals.
Section lengths were measured using a reticle and the average number of
UV-damaged cells per millimeter of interfollicular epidermis was
determined. For p53 quanti®cation, we scored alternate cross-sections (to
those used for CPD analyses) and averaged the single cell and cluster
frequencies per unit length of section. Mean and standard error of the
mean (SEM) were determined for each group and differences between
groups were calculated using one-way ANOVA (SigmaStat, SPSS).
RESULTS
Immuno¯uorescence microscopy was used to quantify relative
CPD frequencies in individual dermal and epidermal cell nuclei in
chronically irradiated mouse skin. Daily irradiation with low UVB
doses resulted in greater numbers of FITC-positive cells and a
progressive increase in the average ¯uorescence per nucleus
(Mitchell et al, 1999). Negligible ¯uorescence was observed in
skin cell nuclei from unirradiated mice. CPD-associated ¯uores-
cence was detectable and uniformly distributed in the epidermis
after 10 d of chronic irradiations but thereafter showed an
increasing nonrandom distribution. In samples biopsied at 20 d
and later, the epidermis showed a somewhat uniform ¯uorescence
®eld punctuated by heavily damaged cells located primarily in the
basal layer. At 40 d after the last treatment heavily damaged nuclei
were still evident although ¯uorescence in the remaining cells was
observed at background levels.
The induction of CPD in mouse skin biopsied immediately after
a single acute exposure to 6 kJ per m2 UVB radiation is shown in
Fig 1(A). The distribution was similar to that observed at 24 h after
chronic high dose treatments (panel B); i.e., high levels of DNA
damage were observed throughout the epidermis and dermis.
Signi®cant epidermal hyperplasia was seen 24 h after the acute
exposure and few FITC-positive cells were evident in the
epidermis at 4 d postirradiation (data not shown). When the 6 kJ
per m2 acute dose was administered to mice with heavily damaged
basal cells (i.e., 60 d after a 60 d course of chronic low dose
irradiation) negligible damage remained in the epidermis at 4 d
postirradiation (data not shown).
In Fig 1(B) CPD ¯uorescence is shown in mouse skin biopsied
24 h after a total accumulated dose of 10 kJ per m2 delivered at
2.0 kJ per m2 per d for 5 d. CPD-speci®c immuno¯uorescence was
signi®cant and variable throughout the epidermis with particularly
high ¯uorescence (and background) evident in the dermis. In
contrast to low daily exposures (see Fig 1D), we observed
immediate proliferation (i.e., within 24±48 h) in the epidermis
after exposure to 2.0 kJ per m2 per d and distribution of heavily
damaged cells throughout (Fig 1B). The thickening of the
epidermis and accumulation of anucleated cells in the stratum
corneum reduced the expected dose to the epidermis and dermis
(compare intensities and frequencies of immunopositive epidermal
nuclei in Figs 1B and D). Radioimmunoassay data of these same
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Figure 1. Distribution of CPD in mouse skin exposed to acute and chronic doses of UVB radiation. Ethanol-®xed sections were reacted
with monoclonal antibodies against CPD and stained with FITC-tagged goat antimouse IgG. (A) Dorsal skin immediately after irradiation with 6.0 kJ
per m2 showing CPD throughout the epidermis; (B) 24 h after 5 d irradiation with 2.0 kJ per m2 per d (total dose 10 kJ per m2) showing CPD
distribution and hyperplasia; (C) 60 d after 5 d irradiation with 2.0 kJ per m2 per d (total dose 10 kJ per m2) showing recovery of normal, undamaged
tissue; (D) 24 h after 20 d irradiation with 0.5 kJ per m2 per d (total dose 10 kJ per m2) showing CPD distribution and lack of hyperplasia.
Scale bar: 50 mm.
Figure 2. The effect of TPA promotion on CPD distribution in mouse skin. Immuno¯uorescence microscopy of CPD was performed as in
Fig 1. (A) Dorsal skin from mice exposed to 0.5 kJ per m2 per d UVB for 40 d (total dose 20 kJ per m2) and treated with 10% acetone 24 h after ®nal
irradiation showing three heavily damaged cells in the basal layer; (B, C) dorsal skin from mice irradiated as in (A) and biopsied 24 h after TPA
treatment showing doublets; (D) dorsal skin from mice irradiated as in panel A and biopsied 48 h after TPA treatment showing doublet in the
suprabasal epidermis and clustered immunopositive nuclei at the top of the hair follicle. Scale bar: 50 mm.
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samples showed signi®cantly greater attenuation of photoproduct
formation in the skin of mice exposed to the higher daily doses of
UVB (Mitchell et al, in press). Effects of high dose chronic
irradiations were transient with normal morphology and negligible
CPD levels measured in the epidermis and dermis at 60 d after the
chronic treatment ended (Fig 1C). We observed no persistent
heavily damaged cells (i.e., at 60 d) in skin in response to the
chronic high dose irradiations. The effects of a low chronic dose
regimen (i.e., 0.5 kJ per m2 per d) on CPD formation are shown in
Fig 1(D). Epidermal thickness was comparable to that seen in
normal skin and immediately after a single high dose of UVB
(Fig 1A) with variable CPD immuno¯uorescence observed
throughout the epidermis and dermis. Cells displaying particularly
high ¯uorescence were observed periodically in the basal layer
(upper left of Fig 1D).
The effects of tumor promotion on the heavily damaged cells
remaining after 40 d chronic UVB were studied using TPA. The
average frequency of heavily damaged basal cells per millimeter in
the acetone control was 1.75 (SEM = 0.22) (shown in Fig 2(A), at
2003 magni®cation). At 24 h after TPA treatment we observed
»3-fold increase in epidermal thickness and much reduced levels of
heavily damaged cells; i.e., 0.12 (SEM = 0.04) damaged cells per
mm in the basal layer and 0.38 (SEM = 0.07) per mm in the
suprabasal epidermis. At 72 h after TPA treatment we detected no
FITC-positive cells in the epidermis. The mean values determined
for the different experimental conditions were signi®cantly differ-
ent. Immunopositive doublets were observed at 24 h at the basal
layer and are shown at 4003 and 10003 magni®cation in
Figs 2(B) and (C), respectively. In Fig 2(D), immunopositive
cells in the suprabasal epidermis and associated with a hair follicle
are shown at 10003 magni®cation. No differences in the frequency
of activated caspase-3-positive (i.e., apoptotic) cells were observed
in the control and TPA-treated epidermis at 24 h (data not shown).
These data suggest that by 24 h after TPA treatment »70% of the
damage-retaining cells had divided suf®ciently (or repaired suf®-
cient damage) to reduce the CPD frequencies to background.
Skin sections excised 24 h after TPA treatment from duplicate
mice were stained with antibodies that bind wild-type and mutant
mouse p53 protein (Fig 3). We found p53-positive cells occurring
individually and in clusters with comparable frequencies. The great
majority of the clusters contained p53-positive cells that appeared
to be laterally contiguous along the basal layer (as shown in Fig 3),
although some quasi-ovoid clusters were noted in the suprabasal
epidermis. We found 0.02 (SEM = 0.01) p53 clusters per mm in
the control and 0.27 (SEM = 0.04) and 0.29 (SEM = 0.07) clusters
per mm at 24 and 72 h post-TPA treatment, respectively. The
differences in the mean values of the acetone and TPA treated
groups are signi®cant (p < 0.001). Individual cells staining positively
for p53 occurred at 0.16 and 0.22 cells per mm at 24 and 72 h,
respectively. There was an average of seven p53-positive cells per
cluster. The distribution of clusters was nonuniform; whereas some
sections contained no clusters, others had considerably more than
the average.
We were interested to see if damage also persisted after a single
exposure to a ``sunburn'' dose of UVB and what effect this
treatment would have on the levels of persistent damage that
accumulated during chronic low dose irradiation. CPD were
visualized at 0, 4, and 60 d after irradiation with 6 kJ per m2 UVB
(2±3 3 MED) in control mice (i.e., receiving no prior exposure)
and in mice chronically exposed to UVB light. In Fig 1(A),
extensive damage is evident (in all cells) in the skin of mice biopsied
immediately after acute irradiation. In contrast, we detected no
immuno¯uorescent cells 4 d after the high acute dose in control
mice receiving no chronic irradiation or in chronically irradiated
mice with heavily damaged basal cells (data not shown). In addition
to loss of ¯uorescence we observed signi®cant epidermal
hyperplasia in these mice. These data suggest that a single
``sunburn'' dose of UVB may serve as a promotion event with
results very similar to those seen after TPA treatment.
The occurrence of basal cells containing persistent photodamage
was not limited to mouse skin as similar cells were observed in
human epidermis. In Fig 4, CPD are shown in biopsies from
patients treated at Dermatologisches Zentrum in Buxtehude,
Germany, for various skin disorders. Background levels of ¯uor-
escence not associated with cell nuclei were seen in unexposed skin
biopsies from the groin area of a 47-y-old female patient with acne
inversa (Fig 4A) particularly along the basement membrane
(Figs 4A and B). In contrast, skin from sun-exposed regions of
two patients showed extensive FITC-positive staining in the
epidermis and dermis. In Fig 4(B) a biopsy from the forehead of a
79-y-old male patient with basal cell carcinoma showed heavily
damaged cells at all levels of the epidermis. This section was taken
from unaffected tissue adjacent to an excised tumor. In Fig 4(C),
skin from the forehead of a 67-y-old male patient admitted for
wrinkle surgery showed a somewhat different distribution of
damage with ¯uorescent nuclei restricted to the surface and basal
layers of the skin. The paucity of intraepidermal damage, compared
to the patient shown in Fig 4(B), may re¯ect intermittent exposure
to sunlight with persistent lesions located at the basal layer and
nascent damage limited to the upper layers of the epidermis (i.e.,
stratum granulosum). In Fig 4(D), a biopsy from the groin region
of a 40-y-old female patient with malignant melanoma is shown.
The section was taken during dissection of a lymph node metastasis
and would have received periodic sunlight exposure during
sunbathing. It is probable that the DNA damage evident in the
FITC-positive basal cells represents persistent damage that was
induced at some considerable time prior to the biopsy.
DISCUSSION
We investigated the formation and fate of DNA damage in the
epidermis of mice chronically irradiated with multiple suberythe-
mal doses of UVB radiation, exposed to a single erythemal dose of
UVB light, or exposed to a single erythemal dose subsequent to
chronic irradiation. We found that signi®cant amounts of photo-
damage accumulated in a small number of epidermal cells after
chronic low dose irradiation and subsequent treatment with TPA
or a ``sunburn dose'' of UVB resulted in complete loss of damage
from the epidermis. In addition, we could detect no persistent
DNA damage in epidermal cells after chronic irradiation that
enhanced cell proliferation (i.e., daily exposure to 2 kJ per m2
UVB). It is noteworthy that both erythemal (i.e., 6 kJ per m2) and
suberythemal (i.e., 2 kJ per m2) UVB exposures induced signi®cant
hyperplasia.
The observation that certain basal cells retain high levels of DNA
damage for several weeks after UV exposure indicates that these
cells are noncycling. Lack of staining by antihuman Melan-A,
Clone A103 (DAKO), speci®c for melanocytes and melanoma cells
Figure 3. Formation of p53 clusters in response to tumor
promotion. Dorsal skin sections from chronically irradiated mice
biopsied 24 h after treatment with TPA and reacted with monoclonal
antibodies that bind wild-type and mutant p53 protein. A linear cluster
of p53-positive cells is shown at the basal layer. Scale bar: 50 mm.
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indicated that these cells were not melanocytes. Indeed, the
behavior of these cells is very similar to the slowly cycling,
carcinogen-retaining basal cells found in the central regions of the
epidermal proliferative units described by Morris and coworkers
(Morris et al, 1986, 1997). Of particular interest is the observation
that treatment of the carcinogen-label-retaining cells with TPA
induces proliferation of the labeled cells within 24 h with
concomitant diffusion of the carcinogen in the basal nuclei. In
our experiments, topical treatment with TPA not only produced
signi®cant loss of the CPD ¯uorescence signal within 24 h but
induced formation of p53-positive cells and clusters (Fig 5). It is
suggested that the slowly cycling, repair-de®cient cells are stem cells
(Morris et al, 1986, 1997). Recent data indicate that hair follicule
stem cells may represent a major source of keratinocyte stem cells in
mouse skin (Taylor et al, 2000). Taylor et al.'s experiments show
that these upper follicular keratinocytes, located in the bulge
region, emigrate into the epidermis in response to a penetrating
wound. In Fig 2, panel D, we observed cells with intermediate
immuno¯uorescent signals associated with the upper portion of a
hair follicle. Such cells may represent heavily damaged stem cells
emigrating from the hair follicle in response to TPA-induced
hyperplasia.
The ability of a subpopulation of basal cells to accumulate CPD
suggests that they are repair-de®cient and quiescent. Global
genome repair of CPD in mouse epidermis is biphasic with some
of the damage (i.e., 10%±30%) rapidly removed within the ®rst 24±
48 h postirradiation and most of the lesions still present 72±120 h
later (Bowden et al, 1975; Ley et al, 1977; Cooke and Johnson,
1978; Johnson, 1978; Qin et al, 1995). Biphasic transcription-
coupled repair in the hairless mouse shows 60% of the CPD
removed from active genes during the ®rst 4 h postirradiation and
no further removal up to 24 h (Ruven et al, 1993). Hence, it is
possible that in the absence of cell division a considerable amount of
damage may accumulate in genomic and transcriptionally active
DNA sequences. DNA damage and mutation hotspots in the p53
tumor suppressor gene (Ziegler et al, 1993) and ras oncogene
(Ananthaswamy and Pierceall, 1990) in squamous and basal cell
carcinomas may represent such sites of persistent damage.
Current models for photocarcinogenesis suggest that chronic UV
confers a selective advantage on cells with a dysfunctional p53 gene
and that reduced apoptosis and increased clonal expansion of these
damaged cells leads to formation of p53 clusters, actinic keratoses,
and, ultimately, carcinomas (Berg et al, 1996; Jonason et al, 1996).
With the removal of the UV stress, the selective advantage is lost
and the damaged cells regress (i.e., produce fewer mutant p53
clusters). Our data suggest that cessation of a chronic UVB stress
may result in removal of a transiently amplifying cell compartment
Figure 4. Distribution of CPD in human skin. (A) Unexposed skin (groin) showing negligible immuno¯uorescent nuclei in the epidermis; (B, C)
chronically exposed skin (forehead) showing immunopositive cells throughout the epidermis and dermis; (D) sporadically exposed skin (groin) showing
a cluster of heavily damaged basal cells. Scale bar: 50 mm.
Figure 5. TPA effects on the frequencies of heavily damaged and
p53-immunopositive cells in the epidermis. Mean and standard
error are shown: j, heavily damaged basal cells; h, p53-immunopositive
cells.
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from the epidermis but leave a subpopulation of latent neoplastic
cells that become activated by a proliferation event (i.e., promo-
tion). In response to promotion it is probable that the majority of
the cells die (e.g., via apoptosis) or enter a truncated proliferative
pathway leading to cell regression. Loss of CPD-associated
immuno¯uorescence in these cells suggests cell death, dilution
through cell division, or recovery of a latent DNA repair capacity.
The number of p53-immunopositive clusters observed after TPA
treatment was »25% of the number of heavily damaged cells lost.
Such a high mutation frequency may arise from the high CPD
frequencies observed in the damage-retaining cells. As we observed
no increase in the number of activated caspase-3-positive cells 24 h
after TPA treatment compared to the control it is doubtful that
apoptosis played a signi®cant role in removal of the damaged cells.
From these results we suggest that a single exposure to a
``proliferative'' dose of UVB may act as a promoter, causing most
(if not all) of the heavily damaged cells located at the basal layer to
enter the proliferative compartment. This event may serve to clear
the skin of latent neoplastic cells and at the same time increase the
immediate risk for preneoplastic lesion formation. Studies correl-
ating skin tumor induction and the frequency of heavily damaged
cells should shed some light on the biologic signi®cance of this
unique but important class of basal stem cells.
Our data have important implications for assessing the risks of
solar UV exposure. Mice treated with 0.5 kJ per m2 UVB showed
negligible observable effects on skin morphology; those treated
with 2 kJ per m2 showed profound hyperplasia soon after the start
of the chronic protocol. Hence, it is possible that a ``threshold''
dose may exist between these two doses under which cells are
initiated and beyond which cells are both initiated and promoted.
In parallel studies we have found that extensive hyperplasia greatly
attenuates the amount of UVB penetration in the epidermis
(Mitchell et al, in press). Hence, a chronic dose of UVB beyond the
hypothetical ``proliferative threshold'' would be more effective as a
cancer promoter than initiator.
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